for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bristol-Myers and Rockefeller University collaborate to develop COVID-19 therapy

Feb 3 (Reuters) - Drugmaker Bristol-Myers Squibb Co on Wednesday entered into an agreement with The Rockefeller University to globally develop, make and sell Rockefeller’s therapy in development to treat COVID-19.

Reporting by Trisha Roy in Bengaluru; Editing by Shinjini Ganguli

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up